The scientist’s investigation covers issues in Lymphangioleiomyomatosis, Pathology, Tuberous sclerosis, Lung and Surfactant protein A. His research in Lymphangioleiomyomatosis intersects with topics in Lung transplantation, Respiratory disease and Pneumothorax, Surgery. His work in Pathology addresses issues such as Cell, which are connected to fields such as Lymphatic system and Molecular biology.
His Tuberous sclerosis study combines topics from a wide range of disciplines, such as Angiomyolipoma, Differential diagnosis, Internal medicine, Interstitial lung disease and Lung biopsy. His Lung research is multidisciplinary, relying on both Metastasis and Etiology. His work deals with themes such as Innate immune system, Collectin and Cell biology, which intersect with Surfactant protein A.
Francis X. McCormack mainly investigates Lymphangioleiomyomatosis, Pathology, Lung, Surfactant protein A and Biochemistry. His work is dedicated to discovering how Lymphangioleiomyomatosis, Sirolimus are connected with Placebo and other disciplines. The study of Pathology is intertwined with the study of Pulmonary alveolar microlithiasis in a number of ways.
In his study, Keratinocyte growth factor and In vivo is strongly linked to Immunology, which falls under the umbrella field of Lung. In his study, Microbiology and Surfactant protein D is inextricably linked to Collectin, which falls within the broad field of Surfactant protein A. His Biochemistry research incorporates themes from Molecular biology and Protein A.
His primary areas of investigation include Lymphangioleiomyomatosis, Pathology, Internal medicine, Cancer research and Lung. His Lymphangioleiomyomatosis study is associated with Tuberous sclerosis. In the subject of general Pathology, his work in Cyst is often linked to Yellow nail syndrome, thereby combining diverse domains of study.
Francis X. McCormack has included themes like Gastroenterology and Cardiology in his Internal medicine study. His Cancer research research also works with subjects such as
Francis X. McCormack spends much of his time researching Lymphangioleiomyomatosis, Pathology, Internal medicine, Lung and Tuberous sclerosis. His Lymphangioleiomyomatosis course of study focuses on Genotype and Angiomyolipoma, TSC2, TSC1, Lung disease and Survival analysis. His Pathology study incorporates themes from Transcriptome and Chronic respiratory failure.
His Internal medicine study which covers Gastroenterology that intersects with Biomarker, Menopause, Gene mutation, Vascular endothelial growth factor and DLCO. His biological study spans a wide range of topics, including Chemokine, Dendritic cell, Myeloid and Monocyte. His research integrates issues of Cell, Uterus, Metastatic neoplasm and Sirolimus in his study of Tuberous sclerosis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis
John J. Bissler;Francis X. McCormack;Lisa R. Young;Jean M. Elwing.
The New England Journal of Medicine (2008)
Efficacy and safety of sirolimus in lymphangioleiomyomatosis.
Francis X. McCormack;Yoshikazu Inoue;Joel Moss;Lianne G. Singer.
The New England Journal of Medicine (2011)
The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lung
Francis X. McCormack;Jeffrey A. Whitsett.
Journal of Clinical Investigation (2002)
The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment.
Jay H. Ryu;Joel Moss;Gerald J. Beck;Jar Chi Lee.
American Journal of Respiratory and Critical Care Medicine (2006)
Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability
Huixing Wu;Alexander Kuzmenko;Sijue Wan;Lyndsay Schaffer.
Journal of Clinical Investigation (2003)
Cutting Edge: The Immunostimulatory Activity of the Lung Surfactant Protein-A Involves Toll-Like Receptor 4
Loïc Guillot;Viviane Balloy;Francis X. McCormack;Douglas T. Golenbock.
Journal of Immunology (2002)
Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages.
C D Gaynor;F X McCormack;D R Voelker;S E McGowan.
Journal of Immunology (1995)
Lymphangioleiomyomatosis: a clinical update.
Francis X. McCormack.
Chest (2008)
Mutational and radiographic analysis of pulmonary disease consistent with lymphangioleiomyomatosis and micronodular pneumocyte hyperplasia in women with tuberous sclerosis.
David Neal Franz;Alan Brody;Cristopher Meyer;Jennifer Leonard.
American Journal of Respiratory and Critical Care Medicine (2001)
Evidence That Lymphangiomyomatosis Is Caused by TSC2 Mutations: Chromosome 16p13 Loss of Heterozygosity in Angiomyolipomas and Lymph Nodes from Women with Lymphangiomyomatosis
Teresa A. Smolarek;Lisa L. Wessner;Francis X. McCormack;Johanna C. Mylet.
American Journal of Human Genetics (1998)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Cincinnati Children's Hospital Medical Center
National Institutes of Health
University of Colorado Denver
Cincinnati Children's Hospital Medical Center
National Jewish Health
Mayo Clinic
University of Colorado Denver
Boston University
University of Colorado Denver
Brigham and Women's Hospital
University of Missouri
Sapienza University of Rome
University of Tübingen
University of Groningen
University of Waikato
University of Wisconsin–Madison
Leibniz Association
University Medical Center Groningen
University of Tasmania
Technion – Israel Institute of Technology
University of Nebraska Medical Center
Vanderbilt University
Icahn School of Medicine at Mount Sinai
Carnegie Mellon University
Newcastle University
University of California, San Francisco